dexmedetomidine + melatonin

Dexmedetomidine + melatonin is an experimental combination of two agents—dexmedetomidine, a selective alpha-2 adrenergic receptor agonist, and melatonin, an endogenous hormone with sedative and chronobiotic properties. This combination has been studied primarily for its anesthetic and sedative effects in preclinical models. Research indicates that the co-administration of these drugs can produce effective surgical anesthesia at lower doses than when either drug is used alone, potentially reducing the side effects associated with higher doses of dexmedetomidine. The mechanism involves synergistic sedation through central nervous system depression via different but complementary pathways—dexmedetomidine acting on alpha-2 adrenergic receptors to inhibit norepinephrine release and melatonin modulating circadian rhythms and sleep induction[1][3][5]. There are no approved brand names or commercial formulations for this specific combination.